Gilead Sciences Discontinued
FDA Approved Drugs

Gilead Sciences Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 8
  • Latest Approval Date Jun 20, 2025
  • Data Source FDA
  • First Approval Date Jun 26, 1996
All
57
View
Unclassified
5
View
Discontinued
8
View
RX
44
View
Company Overview

Company

Gilead Sciences Discontinued

Country

U.S.A

Website

Visit Website

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Gilead Sciences Discontinued

333 Lakeside Drive Foster City, CA 94404

U.S.A

www.gilead.com/ View on Map
FDA Approved Drug Records ( 8 records )
2006
12 Jul
Discontinued Application: 21937

Drug Name

ATRIPLA

Product Number

1

Dosage Form

-

Strength

600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-07-12

21937 / 1

Active Ingredient

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Application Number

21937

Product Number

1

Dosage Form

-

Strength

600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-07-12

Regulatory Status

Discontinued

2002
20 Sep
Discontinued Application: 21449

Drug Name

HEPSERA

Product Number

1

Dosage Form

-

Strength

10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2002-09-20

21449 / 1

Active Ingredient

ADEFOVIR DIPIVOXIL

Application Number

21449

Product Number

1

Dosage Form

-

Strength

10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2002-09-20

Regulatory Status

Discontinued

2014
24 Sep
Discontinued Application: 203094

Drug Name

TYBOST

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2014-09-24

203094 / 1

Active Ingredient

COBICISTAT

Application Number

203094

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2014-09-24

Regulatory Status

Discontinued

2025
20 Jun
Discontinued Application: 203094

Drug Name

TYBOST

Product Number

2

Dosage Form

-

Strength

90MG

Approval Date

2025-06-20

203094 / 2

Active Ingredient

COBICISTAT

Application Number

203094

Product Number

2

Dosage Form

-

Strength

90MG

Approval Date

2025-06-20

Regulatory Status

Discontinued

2020
22 Oct
Discontinued Application: 214787

Drug Name

VEKLURY

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2020-10-22

214787 / 2

Active Ingredient

REMDESIVIR

Application Number

214787

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2020-10-22

Regulatory Status

Discontinued

1996
26 Jun
Discontinued Application: 20638

Drug Name

VISTIDE

Product Number

1

Dosage Form

-

Strength

EQ 375MG BASE/5ML (EQ 75MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-06-26

20638 / 1

Active Ingredient

CIDOFOVIR

Application Number

20638

Product Number

1

Dosage Form

-

Strength

EQ 375MG BASE/5ML (EQ 75MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-06-26

Regulatory Status

Discontinued

2014
24 Sep
Discontinued Application: 203093

Drug Name

VITEKTA

Product Number

1

Dosage Form

-

Strength

85MG

Approval Date

2014-09-24

203093 / 1

Active Ingredient

ELVITEGRAVIR

Application Number

203093

Product Number

1

Dosage Form

-

Strength

85MG

Approval Date

2014-09-24

Regulatory Status

Discontinued

2014
24 Sep
Discontinued Application: 203093

Drug Name

VITEKTA

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2014-09-24

203093 / 2

Active Ingredient

ELVITEGRAVIR

Application Number

203093

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2014-09-24

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    8 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    57 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
8 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ATRIPLA

Application Number

21937

Product Number

1

Active Ingredient

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Dosage Form

-

Strength

600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit